After opening the day marginally higher, the Indian benchmark climbed further as the session progressed and ended the day higher.

Equity benchmark indices ended higher for the second straight trading session on Friday, led by gains in pharma, banking shares. Select auto and energy stocks also logged smart gains.

At the closing bell, the BSE Sensex closed higher by 329 points (up 0.4%).

Meanwhile, the NSE Nifty closed 103 points higher (up 0.4%).

Cipla, SBI, and Bajaj Auto are among the top gainers today.

TCS, Tata Steel, and Tech Mahindra, on the other hand, were among the top losers today.

The GIFT Nifty was trading at 25,40,3 up by 143 points at the time of writing.

The BSE MidCap index ended 0.4% higher, and the BSE SmallCap index ended 0.6% higher.

Sectoral indices were mixed with stocks in the banking sector, realty sector, and telecom sector, witnessing buying. Meanwhile, stocks in the metal sector and the oil & gas sector are witnessing selling pressure.

The rupee is trading at 88.7 against the US$.

Gold prices for the latest contract on MCX are trading 0.8% higher at Rs 120,765 per 10 grams.

Meanwhile, silver prices were trading 1.1% up at Rs 147,924 per 1 kg.
 

Why Metal Stocks Are Falling

In news from the metal stocks, the shares of metal companies fell in trade on October 10, bucking the broader market uptrend. The sharp decline pushed the Nifty Metal index down over 1%, making it the only sectoral loser today.

The fall comes amid a strengthening US dollar and a weakening rupee, which stood at 88.69 against the dollar at 3:25 pm, just above last week's all-time low of 88.80.

Since most global commodities-including metals like copper, aluminum, zinc, gold, and silver-are priced in dollars, a stronger dollar makes them more expensive for buyers using other currencies.

Meanwhile, in geopolitical developments, Israel and Hamas have agreed to the first phase of a US-mediated truce plan for Gaza, including a ceasefire and hostage deal, potentially marking a first step toward ending the two-year-old conflict in the region.
 

Textile Stocks Surge Up to 11%

Moving on, the shares of textile companies jumped on October 10 after Prime Minister Narendra Modi spoke with US President Donald Trump over the phone, reviewing progress in trade negotiations.

The prospect of renewed talks and a potential trade deal between India and the US boosted investor sentiment, particularly for export-oriented textile stocks.

Kitex Garments shares rallied nearly 11% to trade at Rs 199.15, while Gokaldas Exports surged about 9% to Rs 800. Pearl Global Industries rose around 3% to Rs 1,305.9, Indo Count Industries gained nearly 9%, and Raymond Lifestyle was up roughly 1%.

PM Modi also tweeted that he congratulated President Trump on the success of the historic Gaza peace plan and reviewed the positive developments in trade negotiations, agreeing to stay in close touch over the coming weeks.

The surge comes after US-imposed 50% tariffs had earlier hit Indian textile exporters, which earn a significant portion of revenue from US exports.
 

Natco Pharma Jumps 6%. Here's Why

Moving on to news from the pharma sector, the shares of Natco Pharma jumped more than 6% on October 10 after the Delhi High Court dismissed Swiss pharma giant Roche's appeal and allowed the Indian company to sell the spinal muscular atrophy (SMA) drug Risdiplam in India.

Roche had filed an appeal at the High Court against a single-judge order passed in March 2025 that had denied an injuction on Natco's sale of the drug in India.

The previous order had noted that the life-saving therapy must remain affordable and accessible. The March order had paved the way for Natco to launch the generic version of Roche's 'Risdiplam' drug.

The single judge bench had factored the challenge of invalidity of Roche's patent and laid special emphasis on the public interest, considering the Swiss company's pricing had rendered the drug inaccessible and unaffordable to the bulk of its patients, Natco said in a statement.

The court highlighted issues around the validity of Roche's patent and prioritized public interest. Following the dismissal of Roche's appeal, Natco announced it will launch the drug immediately, pricing it at Rs 15,900 per unit.
 

Prosus to Raise ixigo Stake to 15%

Dutch technology investor Prosus, which acquired a 10.1% stake in travel aggregator ixigo (via its parent Le Travenues Technology) on October 10, is planning another deal to increase its holding in the online travel agency, according to Moneycontrol report.

Through the upcoming deals, Prosus will raise its stake from 10.1% to around 15%. Peak XV Partners is set to sell about 3% of its shares, while Elevation Capital will sell another 2%, allowing Prosus to boost its holding by an additional 5%.

Currently, Peak XV Partners holds 10% in ixigo, while Elevation Capital owns 5%, according to market intelligence platform Screener. Prosus has already invested Rs 1,295 crore to acquire its 10.1% stake through preference shares, with the funds directed into ixigo for operational purposes.

More By This Author:

Sensex Today Trades Higher; Metal Index Down 1%
Sensex Today Ends 398 Points Higher; Nifty Above 25,150
Nifty Above 25,000; Tata Steel & Hindalco Top Gainers